Sorafenib Completed Phase 1 Trials for Urethral Cancer / Bladder Cancers / Renal Pelvis Cancer / Transitional Cell Carcinoma / Ureteral Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01844947Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
NCT00544609Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent